Table 3.

Quality of life, illness perceptions and distress scores at baseline for evaluable patients (mean, SD)

	FMD (n = 54)	Regular diet (n = 58)	p value
EORTC QoL-C30 domains
Global Health	79.5 (18.72)	80.5 (19.72)	0.787
Physical functioning	96.4 (6.44)	93.7 (11.13)	0.117
Role functioning	86.7 (22.08)	90.1 (17.78)	0.372
Emotional functioning	69.9 (20.59)	75.3 (20.17)	0.163
Cognitive functioning	84.2 (18.82)	89.4 (16.72)	0.128
Social functioning	88.6 (18.26)	92.0 (13.33)	0.264
EORTC QoL-C30 symptoms
Fatigue	23.0 (24.65)	19.0 (18.26)	0.320
Nausea	4.2 (12.92)	4.3 (11.91)	0.977
Pain	7.6 (14.98)	11.5 (16.28)	0.187
Dyspnea	3.7 (10.57)	4.6 (11.59)	0.671
Insomnia	32.7 (30.42)	26.4 (31.07)	0.280
Appetite loss	14.5 (24.65)	9.8 (18.74)	0.247
Constipation	4.85 (13.48)	6.9 (21.41)	0.547
Diarrhea	2.4 (10.84)	2.3 (10.56)	0.950
Financial difficulties	3.8 (12.51)	2.9 (9.44)	0.668
EORTC Qol-BR23 scores
Body image	90.3 (14.23)	89.9 (16.65)	0.889
Sexual functioning	76.1 (19.18)	77.0 (22.26)	0.809
Sexual enjoyment	56.1 (31.10)	58.1 (32.17)	0.802
Future perspective	47.9 (27.04)	42.0 (31.57)	0.287
EORTC Qol-BR23 symptoms
Systemic side effects	9.6 (10.58)	10.5 (14.25)	0.709
Upset by hair loss	33.3 (23.57)	16.7 (18.26)	0.218

	FMD (n = 33)	Regular diet (n = 47)	p value
BIPQ
Understanding	7.67 (1.61)	7.13 (1.61)	0.149
Consequences	6.33 (2.04)	6.28 (1.87)	0.898
Timeline	4.45 (1.75)	4.89 (1.90)	0.297
Personal control	4.39 (1,92)	4.43 (1.93)	0.927
Treatment control	3.48 (1.79)	3.74 (2.05)	0.558
Identity	5.73 (1.88)	5.83 (1.59)	0.793
Concern	6.09 (2.28)	5.78 (1.99)	0.525
Emotional response	5.55 (2.21)	5.33 (2.26)	0.669

	FMD (n = 49)	Regular diet (n = 55)	p value
Distress thermometer	5.02 (2.10)	5.13 (2.18)	0.800